Healthy adults
Conditions
Interventions
=Evaluation of the effectiveness= -Intake USRP002(development code) -Washout for 1 week -Intake placebo =Analysis of biokinetics= -Washout for 1 week from the evaluation of the effectiveness -I
Sponsors
Kao Corporation
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: Healthy males
Exclusion criteria
Exclusion criteria: 1.Subjects who attend a hospital or who take drugs 2.Subjects who are always under the weather 3.Subjects who underwent the surgery of urinary functions 4.Subjects who have had brain spinal cord injury, cystitis, vesicoureteral reflux, ureteral stone, prostatitis, urethritis or prostatic hyperplasia 5.Subjects who have had severe diseases 6.Subjects who participated several blood collections in a day within 3 months 7.Subjects who feel bad by blood collection 8.Subjects who use medical equipment such as pacemaker 9.Subjects who has allergy to medical tapes or electrodes 10.Subjects who participate in the other examinations which have an influence on this examination 11.Subjects deemed inappropriate to participate in this study by the principle investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Objective indicators on urinary functions after the single intake of USRP002(development code) | — |
Secondary
| Measure | Time frame |
|---|---|
| Objective indicators on autonomic nervous activity and components in blood and urine after the single intake of USRP002(development code) | — |
Countries
Japan
Contacts
Public ContactNaoya Kitamura
Kao Corporation Biological Science Research
Outcome results
None listed